Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBenchmark Holdings Regulatory News (BMK)

  • There is currently no data for BMK

Contract Win

7 Mar 2017 08:00

RNS Number : 7108Y
Benchmark Holdings PLC
07 March 2017
 

 

RNS Reach

7 March 2017

Benchmark Holdings plc("Benchmark" or the "Company")

 

Contract win for Benchmark

Benchmark announces today that it has signed a long-term agreement with SalMar ASA ("SalMar") to provide genetics, health and knowledge services to the company. The full suite of services the Company is providing illustrates Benchmark's leading position in the market, as well as its ability to offer a wide spread of products and solutions across the salmon's life cycle. SalMar is one of world's leading salmon producers.

Benchmark will, through it's subsidiary SalmoBreed AS, form a 50/50 joint venture for the production of SalMar's salmon strain, Rauma. This joint venture to be called 'SalMar Genetic AS', will be formed by a demerger of SalMar's salmon production facility in Reistad, Norway. Benchmark will take full responsibility for managing the breeding programme through its subsidiary Akvaforsk Genetics Center AS.

The agreement also includes sales of eggs from Benchmark's land based sites in Iceland and once commissioned from its Salten site in Norway. The Benchmark group will also provide fish health services, diagnostics, and health products.

Malcolm Pye, CEO of Benchmark, said;

 

"We are delighted to sign an agreement with such a blue-chip partner in the salmon market. It is testament to our customers' recognition of the benefits of our growing, integrated package of products and services, as well as our ability to enhance value for producers and contribute towards the overall sustainability of the aquaculture industry."

 

 

- ENDS -

 

For further information, please contact:

 

Benchmark Holdings plc

Tel: 020 7920 3150

Malcolm Pye, CEO

Roland Bonney, COO

Rachel Aninakwah, Communications

Numis

Tel: 020 7260 1000

Michael Meade / Freddie Barnfield (NOMAD)

James Black (Corporate Broking)

Tavistock

Tel: 020 7920 3150

Niall Walsh / Simon Hudson

 

 

Notes to Editors:

Benchmark challenges the status quo in aquaculture, agriculture and animal healthcare.

 

Since 2000, Benchmark has consistently worked to build a platform to serve its customers, helping farmers to take control of their biological environment through the combination of genetics, nutrition, health and knowledge services. Through its in-depth knowledge of animal biology Benchmark is able to tackle the key issues in the aquaculture, livestock and companion animal sectors.

 

The Company has proven distribution capabilities in high growth markets and operates internationally with R&D facilities, commercial farms, diagnostic laboratories, manufacturing sites, production facilities and commercial offices across 27 countries in five continents. As at 28 February 2017, Benchmark employed 900 people. 

 

For further information on Benchmark please visit www.benchmarkplc.com

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAJRMRTMBIMMFR
Date   Source Headline
28th Feb 20257:00 amRNSQ1 Results
11th Feb 20257:00 amRNSNotice of AGM
7th Feb 202511:05 amRNSNotice of Q1 Results
31st Jan 20257:00 amRNSTotal Voting Rights
7th Jan 20257:00 amRNSPublication of Annual Report
31st Dec 20247:00 amRNSTotal Voting Rights
16th Dec 20241:00 pmRNSResult of General Meeting
12th Dec 20247:01 amRNSChairman Appointment
12th Dec 20247:01 amRNSQ4 Results
12th Dec 20247:00 amRNSFull Year Results
29th Nov 202411:30 amRNSTotal Voting Rights
27th Nov 20249:12 amRNSForm 8.5 (EPT/RI) - Benchmark Holdings plc
26th Nov 20243:00 pmRNSNotice of GM
26th Nov 202412:56 pmGNWForm 8.3 - [BENCHMARK HOLDINGS PLC - 25 11 2024] - (CGAML)
26th Nov 202411:15 amRNSForm 8.3 - Benchmark Holdings plc
26th Nov 20249:39 amRNSForm 8.5 (EPT/RI) - Benchmark Holdings plc
25th Nov 20249:54 amRNSForm 8.5 (EPT/RI) - Benchmark Holdings plc
25th Nov 20247:00 amRNSNotice of Q4 and Full Year Results
25th Nov 20247:00 amRNSDisposal of the Genetics Business
22nd Nov 20249:22 amRNSForm 8.5 (EPT/RI) - Benchmark Holdings plc
22nd Nov 20247:00 amRNSForm 8.3 - Benchmark Holdings plc
21st Nov 202410:15 amRNSForm 8.5 (EPT/RI) - Benchmark Holdings plc
21st Nov 20247:00 amRNSForm 8.3 - Benchmark Holdings plc
20th Nov 20249:53 amRNSForm 8.5 (EPT/RI) - Benchmark Holdings plc
15th Nov 20249:21 amRNSForm 8.5 (EPT/RI) - Benchmark Holdings plc
14th Nov 20249:18 amRNSForm 8.5 (EPT/RI) - Benchmark Holdings plc
13th Nov 20249:48 amRNSForm 8.5 (EPT/RI) - Benchmark Holdings plc
12th Nov 20249:39 amRNSForm 8.5 (EPT/RI) - Benchmark Holdings plc
12th Nov 20247:00 amRNSForm 8.3 - Benchmark Holdings Plc
7th Nov 20249:27 amRNSForm 8.5 (EPT/RI) - Benchmark Holdings plc
6th Nov 20249:25 amRNSForm 8.5 (EPT/RI) - Benchmark Holdings plc
5th Nov 202410:00 amRNSRule 2.9 Announcement
5th Nov 20249:21 amRNSForm 8.5 (EPT/RI) - Benchmark Holdings plc
31st Oct 20249:57 amRNSForm 8.5 (EPT/RI) - Benchmark Holdings plc
31st Oct 20247:00 amRNSTotal Voting Rights
30th Oct 202411:08 amRNSForm 8.5 (EPT/RI) - Benchmark Holdings plc
29th Oct 20249:54 amRNSForm 8.5 (EPT/RI) - Benchmark Holdings plc
28th Oct 20249:50 amRNSForm 8.5 (EPT/RI) - Benchmark Holdings plc
25th Oct 202410:34 amRNSForm 8.5 (EPT/RI) - Benchmark Holdings plc
24th Oct 202411:21 amRNSForm 8.5 (EPT/RI) - Benchmark Holdings plc
23rd Oct 202410:33 amRNSForm 8.5 (EPT/RI) - Benchmark Holdings plc
22nd Oct 202411:43 amRNSForm 8.5 (EPT/RI) - Benchmark Holdings plc
22nd Oct 202410:07 amRNSForm 8.5 (EPT/RI) - Benchmark Holdings plc
21st Oct 202411:02 amRNSForm 8.5 (EPT/RI) - Benchmark Holdings plc
18th Oct 202410:21 amRNSForm 8.5 (EPT/RI) - Benchmark Holdings plc
17th Oct 20249:59 amRNSForm 8.5 (EPT/RI) - Benchmark Holdings plc
11th Oct 202410:51 amRNSForm 8.5 (EPT/RI) - Benchmark Holdings plc
10th Oct 202410:13 amRNSForm 8.5 (EPT/RI) - Benchmark Holdings plc
9th Oct 202410:38 amRNSForm 8.5 (EPT/RI) - Benchmark Holdings plc
7th Oct 202411:41 amRNSForm 8.5 (EPT/RI) - Benchmark Holdings plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.